The trademark application SeptiCyte was filed by ImmuneXpress Pty Ltd, a corporation established under the laws of the Commonwealth of Australia (the "Applicant"). The application was published for oppositions on February 25, 2020, and it was registered by office on June 4, 2020 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Goods And Services
The mark was filed in class 1 with Biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite impression, inflammation, immune-suppression, immune disorders, for diagnosis and treatment of sepsis.
The mark was filed in class 5 with Clinical diagnostics for medical or veterinary use and biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders..
The mark was filed in class 10 with following description of goods:
Surgical and medical apparatus and instruments
Diagnostic tests
Diagnostic testing kits in this class
Point of care medical devices.
The mark was filed in class 44 with following description of goods:
Medical services
Pathology services
Medical and pathology services being the analysis of body fluid samples
Medical services being molecular diagnostic services
Taking of body fluid samples of others
Information, advisory and consultancy services in relation to the aforementioned.